Cantor Fitzgerald’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Buy |
55,223
+17,993
| +48% | +$1.24M | 0.07% | 57 |
|
|
2025
Q1 | $2.59M | Buy |
37,230
+2,157
| +6% | +$150K | 0.05% | 52 |
|
|
2024
Q4 | $3.02M | Buy |
+35,073
| New | +$3.02M | 0.06% | 31 |
|
|
2024
Q3 | – | Sell |
-5,100
| Closed | -$728K | – | 252 |
|
|
2024
Q2 | $728K | Sell |
5,100
-2,696
| -35% | -$385K | 0.14% | 85 |
|
|
2024
Q1 | $1M | Buy |
+7,796
| New | +$1M | 0.24% | 60 |
|
|
2023
Q4 | – | Sell |
-3,971
| Closed | -$361K | – | 450 |
|
|
2023
Q3 | $361K | Buy |
+3,971
| New | +$361K | 0.01% | 345 |
|
|
2023
Q1 | – | Sell |
-6,400
| Closed | -$433K | – | 703 |
|
|
2022
Q4 | $433K | Buy |
+6,400
| New | +$433K | 0.01% | 480 |
|